Live Quote · NASDAQNKTRHealthcare· Biotechnology

Nektar Therapeutics

$30.20▼ 7.19%($-2.34)
MKT CAP $866.38MNEXT EARNINGS Mar 11, 2027
50%
Bullish
TickerSpark Score
42/100
▌ Weak
53
Valuation
40
Profitability
10
Growth
76
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NKTR research report →

Analyst Price Target
$107.20+255.0% vs. today

Range $50 – $153

Analyst RatingBuy
22 Buy6 Hold5 Sell

Price Chart

-45.20% · this period
$100.35$65.27$30.20Nov 20May 26Nov 20
52-Week Range0% of range
Low
$30.13
Current
$30.20
High
$109.00